| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Alcon Research |
| Information provided by: | Alcon Research |
| ClinicalTrials.gov Identifier: | NCT00051194 |
Purpose
To compare the intraocular pressure(IOP)-lowering efficacy of morning or evening instillations of a combination IOP-lowering therapy in patients with open-angle glaucoma or ocular hypertension.
| Condition | Intervention | Phase |
|
Glaucoma, Open-Angle Ocular Hypertension |
Drug: Combination IOP Lowering Therapy |
Phase II |
| Genetics Home Reference related topics: | early-onset glaucoma |
| MedlinePlus related topics: | Glaucoma High Blood Pressure |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
| Official Title: | A 6-Week Safety and Efficacy Study of Combination IOP-Lowering Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension. |
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Adult patients of any race and either sex with open angle glaucoma or ocular hypertension.
Contacts and Locations More Information
| Study ID Numbers: | C-02-03 |
| First Received: | January 3, 2003 |
| Last Updated: | March 3, 2006 |
| ClinicalTrials.gov Identifier: | NCT00051194 |
| Health Authority: | United States: Food and Drug Administration |
|
|
|
|
|
